The full text of this article hosted at iucr.org is unavailable due to technical difficulties.

Brain imaging of 18F‐fallypride in normal volunteers: Blood analysis, distribution, test‐retest studies, and preliminary assessment of sensitivity to aging effects on dopamine D‐2/D‐3 receptors

Jogeshwar Mukherjee

Corresponding Author

E-mail address:mukherjj@uci.edu

Department of Nuclear Medicine/PET, Kettering Medical Center, Dayton, Ohio 45429

Brain Imaging Center, 162 Irvine Hall, Department of Psychiatry & Human Behavior, University of California‐Irvine, Irvine, CA 92697‐3960
Search for more papers by this author
Bradley T. Christian

Department of Nuclear Medicine/PET, Kettering Medical Center, Dayton, Ohio 45429

Search for more papers by this author
Kelly A. Dunigan

Department of Nuclear Medicine/PET, Kettering Medical Center, Dayton, Ohio 45429

Search for more papers by this author
Bingzhi Shi

Department of Nuclear Medicine/PET, Kettering Medical Center, Dayton, Ohio 45429

Search for more papers by this author
Tanjore K. Narayanan

Department of Nuclear Medicine/PET, Kettering Medical Center, Dayton, Ohio 45429

Search for more papers by this author
Martin Satter

Department of Nuclear Medicine/PET, Kettering Medical Center, Dayton, Ohio 45429

Search for more papers by this author
Joseph Mantil

Department of Nuclear Medicine/PET, Kettering Medical Center, Dayton, Ohio 45429

Search for more papers by this author
First published: 05 September 2002
Cited by: 131

Abstract

Human studies of dopamine D2/D3 receptors using 18F‐fallypride‐PET in normal volunteers were performed to evaluate brain distribution in striatal and extrastriatal regions, evaluate metabolites in blood plasma, establish PET imaging protocol for this new radiotracer, evaluate graphical methods of analysis to quantitate D2/D3 receptors, and assess the ability of 18F‐fallypride to measure changes in D2/D3 receptors with aging as a model. Subjects (6; 21–63 years) had a PET scan on a Siemens HR+ scanner with 18F‐fallypride and a T1‐weighted MRI scan on a 1.5T GE scanner for purposes of anatomical coregistration with PET. A 3‐h PET scan with 18F‐fallypride (0.07 mCi/Kg) was carried out on each subject and repeated in 4–6 weeks. Arterial or arterialized venous blood was obtained in all subjects in order to evaluate blood activity levels and analyze metabolites in the plasma. Brain regions‐of‐interest were identified and drawn using PET and PET‐MR coregistered images. PET data was analyzed using graphical methods in which cerebellum was used as the reference region providing distribution volume ratios (DVR) from which binding potential (BP) was derived and used as a measure of concentration of receptors. Distribution of 18F‐fallypride was consistent in all subjects studied and the rank order of receptor concentration was putamen > caudate > thalamus = pituitary > amygdala > colliculi > substantia nigra > hippocampus = temporal cortex > parietal cortex = occipital cortex = orbitofrontal cortex. For younger subjects, BP ranged from 37 for the putamen to 0.4 for orbitofrontal cortex, with a test–retest error of about 10%. Both hydrophilic and lipophilic metabolites were observed in arterial blood plasma and analyses showed approx. 30–40% of plasma radioactivity at 3 h was 18F‐fallypride. With aging, all brain regions exhibited a significant decrease (>10% per decade) in binding of 18F‐fallypride. PET studies with 18F‐fallypride are thus suitable to study changes in D2/D3 receptors in striatal and extrastriatal brain regions. Synapse 46:170–188, 2002. © 2002 Wiley‐Liss, Inc.

Number of times cited: 131

  • , Fluorine-18 Radiolabeling Strategies—Advantages and Disadvantages of Currently Applied Labeling Methods, Late-Stage Fluorination of Bioactive Molecules and Biologically-Relevant Substrates, 10.1016/B978-0-12-812958-6.00002-1, (29-103), (2019).
  • , Human brain imaging of nicotinic acetylcholine α4β2* receptors using [18F]Nifene: Selectivity, functional activity, toxicity, aging effects, gender effects, and extrathalamic pathways, Journal of Comparative Neurology, 526, 1, (80-95), (2017).
  • , Motivation and Memory, Stevens' Handbook of Experimental Psychology and Cognitive Neuroscience, (1-36), (2018).
  • , Low Striatal Dopamine D2-type Receptor Availability is Linked to Simulated Drug Choice in Methamphetamine Users, Neuropsychopharmacology, 43, 4, (751), (2018).
  • , Acute effect of intravenously applied alcohol in the human striatal and extrastriatal D2/D3 dopamine system, Addiction Biology, 22, 5, (1449-1458), (2016).
  • , Structural Neuroimaging in Geropsychology, Encyclopedia of Geropsychology, 10.1007/978-981-287-082-7_342, (2294-2301), (2017).
  • , Effects of flow changes on radiotracer binding: Simultaneous measurement of neuroreceptor binding and cerebral blood flow modulation, Journal of Cerebral Blood Flow & Metabolism, (0271678X1772541), (2017).
  • , The impact of common dopamine D2 receptor gene polymorphisms on D2/3 receptor availability: C957T as a key determinant in putamen and ventral striatum, Translational Psychiatry, 7, 4, (e1091), (2017).
  • , D2/D3 dopamine receptor binding with [F-18]fallypride correlates of executive function in medication-naïve patients with schizophrenia, Schizophrenia Research, 10.1016/j.schres.2017.05.017, (2017).
  • , Reduced effects of age on dopamine D2 receptor levels in physically active adults, NeuroImage, 148, (123), (2017).
  • , Automation of the Radiosynthesis of Six Different 18F-labeled radiotracers on the AllinOne, EJNMMI Radiopharmacy and Chemistry, 10.1186/s41181-016-0018-0, 1, 1, (2016).
  • , Distinct Medial Temporal Lobe Network States as Neural Contexts for Motivated Memory Formation, The Hippocampus from Cells to Systems, 10.1007/978-3-319-50406-3_15, (467-501), (2017).
  • , Small Molecule Receptor Ligands for PET Studies of the Central Nervous System—Focus on G Protein Coupled Receptors, Seminars in Nuclear Medicine, 10.1053/j.semnuclmed.2017.05.002, 47, 5, (524-535), (2017).
  • , Male Behaviors IV: Ageing Brain, Basics of Human Andrology, 10.1007/978-981-10-3695-8_20, (349-362), (2017).
  • , 18 F-fallypride PET-CT of dopamine D2/D3 receptors in patients with sporadic amyotrophic lateral sclerosis, Journal of the Neurological Sciences, 377, (79), (2017).
  • , Striatal dopamine D1-type receptor availability: no difference from control but association with cortical thickness in methamphetamine users, Molecular Psychiatry, (2017).
  • , Radiologic Factors Predicting Deterioration of Mental Status in Patients with Acute Traumatic Subdural Hematoma, World Neurosurgery, 10.1016/j.wneu.2017.12.025, (2017).
  • , Beneficial effects of dietary restriction in aging brain, Journal of Chemical Neuroanatomy, (2017).
  • , Comparative assessment of 18F‐Mefway as a serotonin 5‐HT1A receptor PET imaging agent across species: Rodents, nonhuman primates, and humans, Journal of Comparative Neurology, 524, 7, (1457-1471), (2015).
  • , Aging and Microglial Activation in Neurodegenerative Diseases, Inflammation, Aging, and Oxidative Stress, 10.1007/978-3-319-33486-8_7, (107-131), (2016).
  • , Occupancy of pramipexole (Sifrol) at cerebral dopamine D2/3 receptors in Parkinson's disease patients, NeuroImage: Clinical, 10.1016/j.nicl.2016.06.007, 12, (41-46), (2016).
  • , Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia part II: Cognition, neuroimaging and genetics, The World Journal of Biological Psychiatry, 10.1080/15622975.2016.1183043, 17, 6, (406-428), (2016).
  • , Variability in paralimbic dopamine signaling correlates with subjective responses to d-amphetamine, Neuropharmacology, 108, (394), (2016).
  • , Placebo analgesia: Self-report measures and preliminary evidence of cortical dopamine release associated with placebo response, NeuroImage: Clinical, 10, (107), (2016).
  • , Social change and access to a palatable diet produces differences in reward neurochemistry and appetite in female monkeys, Physiology & Behavior, 162, (102), (2016).
  • , The Chronic Exercise–Cognition Interaction in Older Adults, Exercise-Cognition Interaction, 10.1016/B978-0-12-800778-5.00014-1, (295-320), (2016).
  • , Age-related changes in binding of the D 2/3 receptor radioligand [ 11 C](+)PHNO in healthy volunteers, NeuroImage, 10.1016/j.neuroimage.2016.02.002, 130, (241-247), (2016).
  • , Sex Differences in Midbrain Dopamine D2-Type Receptor Availability and Association with Nicotine Dependence, Neuropsychopharmacology, 41, 12, (2913), (2016).
  • , Relationship of Alexithymia Ratings to Dopamine D2-type Receptors in Anterior Cingulate and Insula of Healthy Control Subjects but Not Methamphetamine-Dependent Individuals, International Journal of Neuropsychopharmacology, 19, 5, (pyv129), (2016).
  • , Midbrain functional connectivity and ventral striatal dopamine D2-type receptors: link to impulsivity in methamphetamine users, Molecular Psychiatry, 21, 11, (1554), (2016).
  • , Emotion dysregulation and amygdala dopamine D2-type receptor availability in methamphetamine users, Drug and Alcohol Dependence, 161, (163), (2016).
  • , Overlapping patterns of brain activation to food and cocaine cues in cocaine abusers, Human Brain Mapping, 36, 1, (120-136), (2014).
  • , Dopamine D3 receptor binding of 18F‐fallypride: Evaluation using in vitro and in vivo PET imaging studies, Synapse, 69, 12, (577-591), (2015).
  • , Structural Neuroimaging in Geropsychology, Encyclopedia of Geropsychology, 10.1007/978-981-287-080-3_342-2, (1-8), (2016).
  • , No evidence for attenuated stress-induced extrastriatal dopamine signaling in psychotic disorder, Translational Psychiatry, 5, 4, (e547), (2015).
  • , Gray-matter volume, midbrain dopamine D2/D3 receptors and drug craving in methamphetamine users, Molecular Psychiatry, 20, 6, (764), (2015).
  • , Long-Term Test–Retest Reliability of Striatal and Extrastriatal Dopamine D2/3 Receptor Binding: Study with [11C]Raclopride and High-Resolution PET, Journal of Cerebral Blood Flow & Metabolism, 35, 7, (1199), (2015).
  • , Neural markers of individual differences in decision-making, Current Opinion in Behavioral Sciences, 10.1016/j.cobeha.2015.08.004, 5, (100-107), (2015).
  • , Investigation of the chick embryo as a potential alternative to the mouse for evaluation of radiopharmaceuticals, Nuclear Medicine and Biology, 42, 3, (226), (2015).
  • , Risk-Taking Behavior: Dopamine D2/D3 Receptors, Feedback, and Frontolimbic Activity, Cerebral Cortex, 25, 1, (236), (2015).
  • , Neuroimaging, Encyclopedia of Geropsychology, 10.1007/978-981-287-080-3_342-1, (1-8), (2016).
  • , Imaging in Drug Development, , 10.1016/bs.pmch.2014.10.002, (231-280), (2015).
  • , Love to Win or Hate to Lose? Asymmetry of Dopamine D2 Receptor Binding Predicts Sensitivity to Reward versus Punishment, Journal of Cognitive Neuroscience, 10.1162/jocn_a_00544, 26, 5, (1039-1048), (2014).
  • , Quantitative, noninvasive, in vivo longitudinal monitoring of gene expression in the brain by co-AAV transduction with a PET reporter gene, Molecular Therapy - Methods & Clinical Development, 1, (14016), (2014).
  • , Imaging dopamine neurotransmission in live human brain, Dopamine, 10.1016/B978-0-444-63425-2.00007-6, (165-182), (2014).
  • , 124I-Epidepride: A PET radiotracer for extended imaging of dopamine D2/D3 receptors, Nuclear Medicine and Biology, 41, 5, (426), (2014).
  • , Towards a therapeutic window of D2/3 occupancy for treatment of psychosis in Alzheimer's disease, with [18F]fallypride positron emission tomography, International Journal of Geriatric Psychiatry, 29, 10, (1001-1009), (2014).
  • , D2 receptor occupancy following lurasidone treatment in patients with schizophrenia or schizoaffective disorder, CNS Spectrums, 19, 02, (176), (2014).
  • , Familial Liability to Psychosis Is Associated With Attenuated Dopamine Stress Signaling in Ventromedial Prefrontal Cortex, Schizophrenia Bulletin, 40, 1, (66), (2014).
  • , Spinal cord dopamine D2/D3 receptors: in vivo and ex vivo imaging in the rat using 18F/11C-fallypride, Nuclear Medicine and Biology, 41, 10, (841), (2014).
  • , Development of 18F-labeled radiotracers for neuroreceptor imaging with positron emission tomography, Neuroscience Bulletin, 30, 5, (777), (2014).
  • , Measuring extrastriatal dopamine release during a reward learning task, Human Brain Mapping, 34, 3, (575-586), (2011).
  • , Effects of acute detoxification of the herbal blend ‘Spice Gold’ on dopamine D2/3 receptor availability: A [18F]fallypride PET study, European Neuropsychopharmacology, 10.1016/j.euroneuro.2013.01.009, 23, 11, (1606-1610), (2013).
  • , Delta-9-Tetrahydrocannabinol-Induced Dopamine Release as a Function of Psychosis Risk: 18F-Fallypride Positron Emission Tomography Study, PLoS ONE, 8, 7, (e70378), (2013).
  • , Synthesis and biological evaluation of 18F-Norfallypride in the rodent brain using PET imaging, Nuclear Medicine and Biology, 40, 5, (697), (2013).
  • , [18F]Fallypride: Metabolism studies and quantification of the radiotracer and its radiometabolites in plasma using a simple and rapid solid-phase extraction method, Nuclear Medicine and Biology, 40, 7, (887), (2013).
  • , Batch-reactor microfluidic device: first human use of a microfluidically produced PET radiotracer, Lab Chip, 13, 1, (136), (2013).
  • , Dopamine Asymmetries Predict Orienting Bias in Healthy Individuals, Cerebral Cortex, 10.1093/cercor/bhs277, 23, 12, (2899-2904), (2012).
  • , Cocaine Cue-Induced Dopamine Release in Amygdala and Hippocampus: A High-Resolution PET [18F]Fallypride Study in Cocaine Dependent Participants, Neuropsychopharmacology, 38, 9, (1780), (2013).
  • , Establishing Test–Retest Reliability of an Adapted [18F]Fallypride Imaging Protocol in Older People, Journal of Cerebral Blood Flow & Metabolism, 33, 7, (1098), (2013).
  • , COMT Val158Met Genotype Selectively Alters Prefrontal [18F]Fallypride Displacement and Subjective Feelings of Stress in Response to a Psychosocial Stress Challenge, PLoS ONE, 8, 6, (e65662), (2013).
  • , [18F]fallypride PET measurement of striatal and extrastriatal dopamine D2/3 receptor availability in recently abstinent alcoholics, Addiction Biology, 17, 2, (490-503), (2011).
  • , Characterization of extrastriatal D2 in vivo specific binding of [18F](N‐methyl)benperidol using PET, Synapse, 66, 9, (770-780), (2012).
  • , PET Evidence for a Role for Striatal Dopamine in the Attentional Blink: Functional Implications, Journal of Cognitive Neuroscience, 10.1162/jocn_a_00255, 24, 9, (1932-1940), (2012).
  • , Sex differences in striatal dopamine D2/D3 receptor availability in smokers and non-smokers, The International Journal of Neuropsychopharmacology, 15, 07, (989), (2012).
  • , Quantification of dopamine D2/3 receptors in rat brain using factor analysis corrected [18F]Fallypride images, NeuroImage, 62, 3, (1455), (2012).
  • , Methodology Poster Abstracts, Journal of Cerebral Blood Flow & Metabolism, 10.1038/jcbfm.2012.80, 32, 1_suppl, (S128-S191), (2012).
  • , Striatal and extrastriatal microPET imaging of D2/D3 dopamine receptors in rat brain with [18F]fallypride and [18F]desmethoxyfallypride, Synapse, 65, 8, (778-787), (2011).
  • , Tinnitus control by dopamine agonist pramipexole in presbycusis patients: A randomized, placebo‐controlled, double‐blind study , The Laryngoscope, 121, 4, (888-893), (2011).
  • , Standardization of fluorine-18 manufacturing processes: New scientific challenges for PET, European Journal of Pharmaceutics and Biopharmaceutics, 10.1016/j.ejpb.2011.01.002, 78, 3, (307-313), (2011).
  • , Antipsychotic Occupancy of Dopamine Receptors in Schizophrenia, CNS Neuroscience & Therapeutics, 17, 2, (97-103), (2010).
  • , Structural and Functional Neuroimaging Methods: Applications to Substance Abuse and Addiction, Neuroimaging in Addiction, (37-82), (2011).
  • , Psychosocial stress is associated with in vivo dopamine release in human ventromedial prefrontal cortex: A positron emission tomography study using [18F]fallypride, NeuroImage, 58, 4, (1081), (2011).
  • , Dopamine D2/D3 receptor availability and venturesomeness, Psychiatry Research: Neuroimaging, 10.1016/j.pscychresns.2011.01.011, 193, 2, (80-84), (2011).
  • , The applicability of SRTM in [18F]fallypride PET investigations: Impact of scan durations, Journal of Cerebral Blood Flow & Metabolism, 31, 9, (1958), (2011).
  • , Endogenous competition against binding of [18F]DMFP and [18F]fallypride to dopamine D2/3 receptors in brain of living mouse, Synapse, 64, 4, (313-322), (2009).
  • , Role of dopamine receptor mechanisms in the amygdaloid modulation of fear and anxiety: Structural and functional analysis, Progress in Neurobiology, 90, 2, (198), (2010).
  • , Motor control and aging: Links to age-related brain structural, functional, and biochemical effects, Neuroscience & Biobehavioral Reviews, 10.1016/j.neubiorev.2009.10.005, 34, 5, (721-733), (2010).
  • , Fetal Dopamine Receptor Characteristics Assessed in Utero, Journal of Cerebral Blood Flow & Metabolism, 30, 8, (1437), (2010).
  • , Can PET/CT imaging advance our understanding of the neurobiology of schizophrenia?, Nuclear Medicine Communications, 10.1097/MNM.0b013e3283341830, 31, 2, (91-93), (2010).
  • , Progress in Psychopharmacotherapy though Molecular Imaging, Systems Biology in Psychiatric Research, (189-206), (2010).
  • , Highly efficient production of [18F]fallypride using small amounts of base concentration, Applied Radiation and Isotopes, 68, 12, (2279), (2010).
  • , Human dopamine receptor D2/D3 availability predicts amygdala reactivity to unpleasant stimuli, Human Brain Mapping, 31, 5, (716-726), (2009).
  • , In vivo imaging of dopamine receptors in a model of temporal lobe epilepsy, Epilepsia, 51, 3, (415-422), (2009).
  • , Alteration of dopamine D2/D3 receptor binding in patients with juvenile myoclonic epilepsy, Epilepsia, 51, 9, (1699-1706), (2010).
  • , 18F-Fallypride binding potential in patients with schizophrenia compared to healthy controls, Schizophrenia Research, 122, 1-3, (43), (2010).
  • , The interrelationship of dopamine D2-like receptor availability in striatal and extrastriatal brain regions in healthy humans: A principal component analysis of [18F]fallypride binding, NeuroImage, 51, 1, (53), (2010).
  • , Molekularbiologische Aspekte der Neuroplastizität, HNO, 58, 10, (973), (2010).
  • , RETRACTED: Relationship between dopamine D2 receptor occupancy, clinical response, and drug and monoamine metabolites levels in plasma and cerebrospinal fluid. A pilot study in patients suffering from first-episode schizophrenia treated with quetiapine, Journal of Psychiatric Research, 44, 12, (754), (2010).
  • , Positron emission tomography imaging of amphetamine‐induced dopamine release in the human cortex: A comparative evaluation of the high affinity dopamine D2/3 radiotracers [11C]FLB 457 and [11C]fallypride, Synapse, 63, 6, (447-461), (2009).
  • , Effect of Menstrual Cycle Phase on Dopamine D2 Receptor Availability in Female Cynomolgus Monkeys, Neuropsychopharmacology, 34, 3, (548), (2009).
  • , Dopamine D2 Receptor Levels in Striatum, Thalamus, Substantia Nigra, Limbic Regions, and Cortex in Schizophrenic Subjects, Biological Psychiatry, 65, 12, (1024), (2009).
  • , Dopamine release during human emotional processing, NeuroImage, 47, 4, (2041), (2009).
  • , BrainPET Poster Session: in vivo Pharmacology and Clinical Applications, Journal of Cerebral Blood Flow & Metabolism, 29, 1_suppl, (S346), (2009).
  • , BrainPET Poster Session: Kinetic Modeling, Journal of Cerebral Blood Flow & Metabolism, 29, 1_suppl, (S312), (2009).
  • , Hyperstimulation of striatal D2 receptors with sleep deprivation: Implications for cognitive impairment, NeuroImage, 10.1016/j.neuroimage.2009.01.003, 45, 4, (1232-1240), (2009).
  • , Increase of striatal dopamine transmission in first episode drug-naive schizophrenic patients as demonstrated by [123I]IBZM SPECT, Psychiatry Research: Neuroimaging, 173, 3, (183), (2009).
  • , PET radiotracers: crossing the blood–brain barrier and surviving metabolism, Trends in Pharmacological Sciences, 30, 8, (431), (2009).
  • , Synthese von 11C‐, 18F‐, 15O‐ und 13N‐Radiotracern für die Positronenemissionstomographie, Angewandte Chemie, 120, 47, (9136-9172), (2008).
  • , Small effect of dopamine release and no effect of dopamine depletion on [18F]fallypride binding in healthy humans, Synapse, 62, 6, (399-408), (2008).
  • , Positron emission tomography ligand activation studies in the sports sciences: Measuring neurochemistry in vivo, Methods, 10.1016/j.ymeth.2008.07.003, 45, 4, (307-318), (2008).
  • , Imagerie moléculaire de la maladie de Parkinson : données actuelles, Médecine Nucléaire, 32, 4, (236), (2008).
  • , Dopamine transporter imaging with [123I]FP-CIT SPECT: potential effects of drugs, European Journal of Nuclear Medicine and Molecular Imaging, 10.1007/s00259-007-0621-0, 35, 2, (424-438), (2007).
  • , Brain-Mapping Techniques for Evaluating Poststroke Recovery and Rehabilitation: A Review, Topics in Stroke Rehabilitation, 15, 5, (427), (2008).
  • , Low dopamine striatal D2 receptors are associated with prefrontal metabolism in obese subjects: Possible contributing factors, NeuroImage, 10.1016/j.neuroimage.2008.06.002, 42, 4, (1537-1543), (2008).
  • , Synthesis of 11C, 18F, 15O, and 13N Radiolabels for Positron Emission Tomography, Angewandte Chemie International Edition, 47, 47, (8998-9033), (2008).
  • , A meta-analytic review of emotion recognition and aging: Implications for neuropsychological models of aging, Neuroscience & Biobehavioral Reviews, 32, 4, (863), (2008).
  • , Die Entstehung und Behandlung der PresbyakusisPathogenesis and treatment of presbyacusis, HNO, 10.1007/s00106-008-1676-3, 56, 4, (429-435), (2008).
  • , Drugs of Abuse and the Aging Brain, Neuropsychopharmacology, 33, 2, (209), (2008).
  • , Die Rolle der kochleären Neurotransmitter in Bezug auf TinnitusThe role of cochlear neurotransmitters in tinnitus, HNO, 10.1007/s00106-007-1624-7, 55, 12, (964-971), (2007).
  • , Radiotracers for a multi‐target approach to the diagnosis of Alzheimer's disease, Journal of Labelled Compounds and Radiopharmaceuticals, 50, 5‐6, (375-379), (2007).
  • , Positron Emission Tomography Quantification of [11C]-(+)-PHNO Binding in the Human Brain, Journal of Cerebral Blood Flow & Metabolism, 27, 4, (857), (2007).
  • , Imaging of Cholinergic and Monoaminergic Neurochemical Changes in Neurodegenerative Disorders, Molecular Imaging and Biology, 9, 4, (243), (2007).
  • , Measuring dopamine neuromodulation in the thalamus: Using [F-18]fallypride PET to study dopamine release during a spatial attention task, NeuroImage, 31, 1, (139), (2006).
  • , Amphetamine-Induced Displacement of [18F] Fallypride in Striatum and Extrastriatal Regions in Humans, Neuropsychopharmacology, 31, 5, (1016), (2006).
  • , The Striatal and Extrastriatal D2/D3 Receptor-Binding Profile of Clozapine in Patients with Schizophrenia, Neuropsychopharmacology, 31, 5, (1027), (2006).
  • , Occupancy of Striatal and Extrastriatal Dopamine D2 Receptors by Clozapine and Quetiapine, Neuropsychopharmacology, 31, 9, (1991), (2006).
  • , Fronto-thalamo-striatal gray and white matter volumes and anisotropy of their connections in bipolar spectrum illnesses, Biological Psychiatry, 57, 7, (733), (2005).
  • , Occupancy of Striatal and Extrastriatal Dopamine D2/D3 Receptors by Olanzapine and Haloperidol, Neuropsychopharmacology, 30, 12, (2283), (2005).
  • , Tinnitus dopaminergic pathway. Ear noises treatment by dopamine modulation, Medical Hypotheses, 65, 2, (349), (2005).
  • , Measurement of d-amphetamine-induced effects on the binding of dopamine D-2/D-3 receptor radioligand, 18F-fallypride in extrastriatal brain regions in non-human primates using PET, Brain Research, 1032, 1-2, (77), (2005).
  • , Imaging technologies in drug development: Anxiety and depression, Drug Discovery Today: Technologies, 10.1016/j.ddtec.2005.11.009, 2, 4, (323-327), (2005).
  • , Effect of amphetamine on [18F]fallypride in vivo binding to D2 receptors in striatal and extrastriatal regions of the primate brain: Single bolus and bolus plus constant infusion studies, Synapse, 54, 1, (46-63), (2004).
  • , Measuring the in Vivo Binding Parameters of [18F]-Fallypride in Monkeys Using a PET Multiple-Injection Protocol, Journal of Cerebral Blood Flow & Metabolism, 24, 3, (309), (2004).
  • , Radiopharmaceuticals for Imaging the Brain, Emission Tomography, 10.1016/B978-012744482-6.50008-9, (89-101), (2004).
  • , In vivo affinity of [18F]fallypride for striatal and extrastriatal dopamine D2 receptors in nonhuman primates, Psychopharmacology, 175, 3, (274), (2004).
  • , Binding characteristics of high‐affinity dopamine D2/D3 receptor agonists, 11C‐PPHT and 11C‐ZYY‐339 in rodents and imaging in non‐human primates by PET, Synapse, 54, 2, (83-91), (2004).
  • , 11C-Fallypride: radiosynthesis and preliminary evaluation of a novel dopamine D2/D3 receptor PET radiotracer in non-human primate brain, Bioorganic & Medicinal Chemistry, 12, 1, (95), (2004).
  • , Differentiation of extrastriatal dopamine D2 receptor density and affinity in the human brain using PET, NeuroImage, 22, 2, (794), (2004).
  • , Positron emission tomography radiochemistry, Neuroimaging Clinics of North America, 13, 4, (671), (2003).
  • , Prefrontal DA Transmission at D1 Receptors and the Pathology of Schizophrenia, The Neuroscientist, 9, 5, (404), (2003).